期刊文献+

利培酮治疗精神分裂症副作用观察及护理 被引量:1

Observation on side reaction of risperidone and nursing in the treatment of schizophrenosis.
下载PDF
导出
摘要 目的:观察利培酮治疗精神分裂症的副作用,并探讨其护理对策.方法:对126例服用利培酮8周的精神分裂症患者,观察药物反应出现的频率及出现时间.结果:利培酮治疗精神分裂症的主要副作用为静坐不能、震颤、恶心呕吐、口干、兴奋激越、失眠、血压变化等.副作用多出现在治疗后1~4周,5周后明显减少.结论:在完成基础护理的同时,对利培酮的药物治疗护理应侧重于早期的失眠和兴奋刺激行为的护理,随着用药剂量的增加,应注意其锥体外系和心血管系副作用的观察和护理. Objective: To observe the side reaction of risperidone in the treatment of schizophrenosis in order to find appropriate nursing, Methods: Observing the frequency and appearing time of side reaction on 126 cases who took risperidone for 8 weeks. Results: The main side reactions were akathisia, tremor, nausea, vomiting and insomnia, etc, The side reaction appeared almost from 1 st to 4th week after the treatment and attenuated since 5 th week. Conclusion: Nursing for schizophreniac should focus on insomnia and irritability in early stage of the treatment and on side reaction in extropyramidal and cardiovascular systems with dosage increased.
作者 田新华 张睿
出处 《齐鲁护理杂志》 2005年第5期421-422,共2页 Journal of Qilu Nursing
关键词 利培酮 精神分裂症 副作用 护理 risperidone schizophrenosis side reaction nursing
  • 相关文献

参考文献3

二级参考文献3

共引文献16

同被引文献17

  • 1Miyamoto S, Duncan GE, Marx CE, et al. Treatments for schizo- phrenia: a critical review of pharmacology and mechanisms of ac- tion of antipsychotic drugs[ J]. Mol Psychiatry, 2005,10( 1 ) :79- 104.
  • 2Rosenheck R, Perlick D, Bingham S, et al. Effectiveness and eost of olanzapine and haloperidol in the treatment of schizophreni- a: a randomized controlled trial [ J ]. JAMA, 2003,290 (20) : 2693 -2702.
  • 3Tollefson GD, Sanger TM. Negative symptoms : a path analytic ap- proach to a double-blind, placebo- and haloperidol-eontrolled clin- ical trial with olanzapine [ J ]. Am J Psychiatry, 1997,154 ( 4 ) : 466 -474.
  • 4Keefe RS, Silva SG, Perkins DO, et al. The effects of atypical antipsyehotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis [ J ]. Schizophr Bull, 1999,25 ( 2 ) : 201-222.
  • 5Tollefson GD, Sanger TM, Lu Y, et al. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanza- pine and haloperidol [ J ]. Arch Gen Psychiatry, 1998,55 ( 3 ) : 250-258.
  • 6Allison DB, Mentore JL, Heo M, et al. Antipsyehotic-induced weight gain : a comprehensive research synthesis [ J ]. Am J Psy- chiatry, 1999,156 ( 11 ) : 1686-1696.
  • 7Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabo- lism in patients with schizophrenia treated with atypical antipsy- chotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis[J]. Arch Gen Psychiatry, 2005, 62(1) :19-28.
  • 8Koro CE, Fedder DO, L'halien GJ, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients [ J ]. Arch Gen Psychiatry, 2002,59 ( 11 ) : 1021-1026.
  • 9Wahlbeck K, Tuunainen A, Ahokas A, et al. Dropout rates in randomised antipsychotic drug trials [ J ]. Psychopharmacology (Bed), 2001,155(3) :230-233.
  • 10Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotie drugs in patients with chronic schizophrenia[ J]. N Engl J Med, 2005,353(12) :1209-1223.

引证文献1

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部